# EDGAR Filing Document

**Accession Number:** 0001802571
**File Stem:** 0001104659-23-032070
**Filing Date:** 2023-3
**Character Count:** 9170
**Document Hash:** f4f05fc326c0ba70d3bdf8cf049067c4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-032070.hdr.sgml**: 20230314

**ACCESSION NUMBER**: 0001104659-23-032070

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230310

**FILED AS OF DATE**: 20230314

**DATE AS OF CHANGE**: 20230314

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Archbold Christine E.
- **CENTRAL INDEX KEY:** 0001802571

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38399
- **FILM NUMBER:** 23729227

**MAIL ADDRESS:**
- **STREET 1:** FRIARS HOUSE, 160 BLACKFRIARS ROAD
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** SEL 8EZ
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AdaptHealth Corp.
- **CENTRAL INDEX KEY:** 0001725255
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HOME HEALTH CARE SERVICES [8082]
- **IRS NUMBER:** 823677704
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 220 WEST GERMANTOWN PIKE
- **STREET 2:** SUITE 250
- **CITY:** PLYMOUTH MEETING
- **STATE:** PA
- **ZIP:** 19462
- **BUSINESS PHONE:** 610-630-6357

**MAIL ADDRESS:**
- **STREET 1:** 220 WEST GERMANTOWN PIKE
- **STREET 2:** SUITE 250
- **CITY:** PLYMOUTH MEETING
- **STATE:** PA
- **ZIP:** 19462

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DFB Healthcare Acquisitions Corp.
- **DATE OF NAME CHANGE:** 20171213

## Ex-24

**Exhibit 24**

**Power of Attorney**

------

Know all by these presents, that the undersigned hereby makes, constitutes and appoints Christopher Joyce, the undersigned's true and lawful attorney-in-fact (each of such persons and their substitutes being referred to herein as the "Attorney-in-Fact"), with full power to act for the undersigned and in the undersigned's name, place and stead, in any and all capacities, to:

&nbsp;&nbsp;&nbsp;&nbsp;1. Prepare, execute, and submit to the Securities
 and Exchange Commission ("SEC") a Form ID, including amendments thereto, and
 any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned
 to make electronic filings with the SEC of reports required or considered by the Attorney-in-Fact
 to be advisable under Section 13 or Section 16 of the Securities Exchange Act of
 1934 (the "Exchange Act") or any rule or regulation of the SEC;

&nbsp;&nbsp;&nbsp;&nbsp;2. Prepare, execute and submit to the SEC,
 AdaptHealth Corp. (the "Company"), and/or any national securities exchange on
 which the Company's securities are listed any and all reports (including any amendments
 thereto) the undersigned, in the undersigned's capacity as an officer, director and/or 10%
 or more stockholder of the Company, is required to file with the SEC, or which the Attorney-in-Fact
 considers it advisable to file with the SEC, under Section 13 or Section 16 of
 the Exchange Act or any rule or regulation thereunder, or under Rule 144 under
 the Securities Act of 1933 ("Rule 144"), with respect to the any security
 of the Company, including Forms 3, 4 and 5, Schedules 13D and 13G, and Forms 144; and

&nbsp;&nbsp;&nbsp;&nbsp;3. Obtain, as the undersigned's representative
 and on the undersigned's behalf, information regarding transactions in the Company's equity
 securities from any third party, including the Company and any brokers, dealers, employee
 benefit plan administrators and trustees, and the undersigned hereby authorizes any such
 third party to release any such information to the Attorney-in-Fact.

The undersigned acknowledges that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) This Power of Attorney authorizes, but
 does not require, the Attorney-in-Fact to act in his or her discretion on information provided
 to such Attorney-in-Fact without independent verification of such information;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any documents prepared or executed by
 the Attorney-in-Fact on behalf of the undersigned pursuant to this Power of Attorney will
 be in such form and will contain such information as the Attorney-in-Fact, in his or her
 discretion, deems necessary or desirable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Neither the Company nor the Attorney-in-Fact
 assumes any liability for the undersigned's responsibility to comply with the requirements
 of Section 13 or Section 16 of the Exchange Act or Rule 144, any liability
 of the undersigned for any failure to comply with such requirements, or any liability of
 the undersigned for disgorgement of profits under Section 16(b) of the Exchange
 Act; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) This Power of Attorney does not relieve
 the undersigned from responsibility for compliance with the undersigned's obligations under
 Section 13 or Section 16 of the Exchange Act, including, without limitation, the
 reporting requirements under Section 13 or Section 16 of the Exchange Act.

The undersigned hereby grants to the Attorney-in-Fact full power and authority to do and perform each and every act and thing requisite, necessary or advisable to be done in connection with the foregoing, as fully, to all intents and purposes, as the undersigned might or could do in person, hereby ratifying and confirming all that the Attorney-in-Fact, or his or her substitute or substitutes, shall lawfully do or cause to be done by authority of this Power of Attorney.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 4 or 5 or Schedules 13D or 13G or Forms 144 with respect to the undersigned's holdings of and transactions in securities of the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Attorney-in-Fact. This Power of Attorney revokes all previous powers of attorney with respect to the subject matter of this Power of Attorney.

IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of March 9, 2023.

---

| |
|:---|
| /s/ Christine Archbold |
| By: Christine Archbold |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Archbold Christine E.<br><sub>(Last) (First) (Middle)</sub><br>C/O ADAPTHEALTH LLC<br>220 WEST GERMANTOWN PIKE, SUITE 250<br><sub>(Street)</sub><br>PLYMOUTH MEETING, PA 19462<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>AdaptHealth Corp. [ AHCO ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-03-10 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief Accounting Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 14499<sup>(1)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) 8,393 of these shares represent restricted stock units and will be settled in common stock upon vesting.

**Remarks:**
Exhibit 24 - Power of Attorney

**Signature:** /s/ Christopher Joyce, as attorney-in-fact for Christine Archbold  
**Date:** 2023-03-14

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**